Back
Speaker illustration

Doctor Daniel Gaudet

ECOGENE-21 and Community gene medicine center, clinical lipidology unit, Montreal (Canada)

Member of:

European Society of Cardiology

Presentations Articles

Transition of patients with familial chylomicronaemia syndrome from volanesorsen to olezarsen: safety and pharmacokinetic results

Event: ESC Congress 2024

Topic: Drug therapy

Session: Secondary prevention: a multifactorial approach

Access
Like
Thumbnail

Rationale and design of the SHASTA-3 and SHASTA-4 studies: randomized, double-blind, placebo-controlled, phase 3 studies of plozasiran in patients with severe hypertriglyceridemia

Event: ESC Congress 2024

Topic: Drug therapy

Session: Lipid-lowering therapies: new findings

Access
Like
Thumbnail

ANGPTL3 antisense oligonucleotide to lower triglycerides

Event: ESC Congress 2020

Topic: Drug therapy

Session: Late-Breaking Science in Lipids

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources